PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35513086-10	2022	HA treatment ameliorated such symptoms through the inhibition of PI3K/Akt signaling pathway.	Hyaluronic Acid	0-2	thymoma viral proto-oncogene 1	Mus musculus	70-73	
30194979-6	2019	TGFbeta induction of Hmga2, Has2as and Has2, and synthesis of hyaluronan were accompanied with activation of Akt and Erk1/2 MAP-kinase signaling and were required for breast cancer cell motility.	Hyaluronic Acid	62-72	thymoma viral proto-oncogene 1	Mus musculus	109-112	
35109928-0	2022	Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner.	Hyaluronic Acid	53-68	thymoma viral proto-oncogene 1	Mus musculus	123-126	
29975419-0	2018	Low-molecular-mass hyaluronan induces pulmonary inflammation by up-regulation of Mcl-1 to inhibit neutrophil apoptosis via PI3K/Akt1 pathway.	Hyaluronic Acid	19-29	thymoma viral proto-oncogene 1	Mus musculus	128-132	
28336457-2	2017	In this study, an Akt inhibitor (quercetin, Qu) was co-delivered with a chemotherapeutic agent (docetaxel, DTX) by using hyaluronic acid (HA)-modified nanoparticles (NPs) as vectors to block metastasis.	Hyaluronic Acid	121-136	thymoma viral proto-oncogene 1	Mus musculus	18-21	
28336457-2	2017	In this study, an Akt inhibitor (quercetin, Qu) was co-delivered with a chemotherapeutic agent (docetaxel, DTX) by using hyaluronic acid (HA)-modified nanoparticles (NPs) as vectors to block metastasis.	Hyaluronic Acid	138-140	thymoma viral proto-oncogene 1	Mus musculus	18-21